A recent study presented at the American Association for Cancer Research (AACR) Annual Meeting on vitamin supplements and their role in the increased risk of cancer and heart disease has raised concerns. Although the [...]
Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]
The AACR has released it's 2013 Cancer Progress report. The report is a comprehensive educational tool that illustrates the return on investments in cancer research and biomedical science. It discusses the various ways medical teams continue [...]
